InsiderTrades

Form 4 for RPRX Royalty Pharma plc

Accepted 2021-09-30 00:00:00 ET · period of report 2021-09-28 · accession 0001209191-21-058170 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-09-30 2021-09-29 RPRX RIGGS RORY B Dir J - Other — +16.3K 631.4K +3% —
DMI 2021-09-30 2021-09-29 RPRX RIGGS RORY B Dir J - Other — -936.4K 789.5K -54% —
DMI 2021-09-30 2021-09-29 RPRX RIGGS RORY B Dir S - Sale $36.35 -63.8K 899.3K -7% -$2.32M
DM 2021-09-30 2021-09-28+ RPRX RIGGS RORY B Dir S - Sale $36.65 -64.6K 615.1K -10% -$2.37M
D 2021-09-30 2021-09-10 RPRX RIGGS RORY B Dir G - Gift $0.00 -7,692 534.1K -1% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Ordinary Shares 2021-09-29 J A 2,334 — 617,446 D By New Ventures I LLC — — (F4) Pro rata distribution from a limited liability company of which the Reporting Person is a member.
2 Common Class A Ordinary Shares 2021-09-29 J D 511,727 — 2,917,358 I — — (F9) New Ventures I LLC distributed these shares to its members on a pro rata basis, for no consideration.
3 Common Class A Ordinary Shares 2021-09-29 S D 22,173 $36.31 3,429,085 I — — (F7) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.25 to $36.50 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4 Common Class A Ordinary Shares 2021-09-29 J D 314,886 — 1,759,654 I — — (F11) New Ventures III LLC distributed these shares to its members on a pro rata basis, for no consideration.
5 Common Class A Ordinary Shares 2021-09-28 S D 40,000 $36.75 639,760 D By New Ventures Select — — (F1) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.58 to $36.96 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6 Common Class A Ordinary Shares 2021-09-29 S D 24,648 $36.50 615,112 D By New Ventures Select — — (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.15 to $36.87 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
7 Common Class A Ordinary Shares 2021-09-29 S D 7,000 $36.67 2,074,540 I — — (F10) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.62 to $36.75 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
8 Common Class A Ordinary Shares 2021-09-29 J A 5,299 — 622,745 D By New Ventures I LLC — — (F4) Pro rata distribution from a limited liability company of which the Reporting Person is a member.
9 Common Class A Ordinary Shares 2021-09-29 J A 8,641 — 631,386 D By New Ventures III LLC — — (F4) Pro rata distribution from a limited liability company of which the Reporting Person is a member.
10 Common Class A Ordinary Shares 2021-09-29 S D 34,604 $36.31 899,306 I By New Ventures III LLC — — (F7) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.25 to $36.50 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
11 Common Class A Ordinary Shares 2021-09-29 J D 109,814 — 789,492 I — — (F8) New Ventures Select distributed these shares to its members on a pro rata basis, for no consideration.
12 Derivative LP interests in RPI US Partners 2019, LP 2021-09-10 G D 7,692 $0.00 534,059 D — · — to — 76,920 Class A Ordinary Shares (F12) No limited partnership interests in RPI US Partners 2019, LP ("RPI US LP") are being exchanged by the Reporting Person. Each limited partnership interest in RPI US LP ("RPI US LP Interest") may be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. Any exchanges will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with an exchange. (F14) Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.